Guifang Ouyang

8PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomedicineMedical mycologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 15, 2026
A Mitochondria-Targeted Flavokawain A Derivative Suppresses Lymphoma by Disrupting Oxidative Phosphorylation.

|Jun 10, 2026
CSF ctDNA Molecular Clearance as a Prognostic Biomarker for Orelabrutinib-Treated Primary Central Nervous System Lymphoma: Insights From Comparison With PET-CT.

|Apr 15, 2026
Cyclophosphamide alters gut microbiota metabolism and structure in lymphoma-bearing mice: implications for dietary modulation.

|Mar 07, 2026
Torque Teno Virus Drives Atypical Acute Promyelocytic Leukemia as a Novel Molecular Subtype.

Xiaosu Zhou, Qitian Mu, Hongwei Chen

|Mar 02, 2026
Whole transcriptome sequencing reveals differences in the pathogenesis of myelodysplastic syndromes and acute myeloid leukemia.

Miao Zhou, Tongyu Li, Yun Li

|Mar 01, 2026
A ROS-Responsive Dimeric Prodrug Nanoassembly for Amplified Epigenetic Therapy of Lymphoma.

Tongyu Li, Wanchuan Zhuang, Shufang Fan

Pageof 2

Frequent Collaborators

1 joint publications

Ping Zhang

1 joint publications

Xiaosu Zhou

1 joint publications

Qitian Mu

1 joint publications

Hongwei Chen